ANTIDEPRESSANTS: Tell All Book: “Side Effects: Death”: by Former Lilly Exec

Many of the horrific school, workplace and
mass shootings that have plagued parts of the world over the years may not have
occurred if the pharmaceutical industry had been completely honest about the
side effects of psychotropic medication, according to the new book Side Effects:

Death – Confessions of a Pharma Insider by former executive director of the
Swedish Branch of Eli Lilly & Company John Virapen.

Virapen claims
that anti-depressants and selective serotonin reuptake inhibitors (SSRIs) were
known to have suicidal and homicidal side effects, even during clinical trials.
Thanks to spin marketing and paid, positive articles in scientific journals, he
points out, the adverse reactions were often ignored or given little thought by

prescribing physicians and patients.

Read More

CYMBALTA: Five Patients Commit Suicide During Clinical Trials: U.S.A.

Cymbalta manufactured by Eli Lilly is a serotonin norepinephrine reuptake inhibitor (SNRI) antidepressant used to treat major depression. It is prescribed to treat pain associated with diabetic peripheral neuropathy, which is a painful nerve disorder associated with diabetes that affects the hands, legs, and feet. Cymbalta has only recently been approved for use to treat fibromyalgia if people can tolerate Cymbalta’s side effects.

The drug works by preventing serotonin and noradrenaline from being reabsorbed back into the nerve cells in the brain. This helps prolong the mood-lightening effect of any released serotonin and noradrenaline, restoring balance to the emotions of the patient. Cymbalta may also be used in the treatment of generalized anxiety disorder.

Read More